Business ❯Finance ❯Company Performance

Revenue Growth

Consumer Spending Growth Strategy Monetization Gene Editing Technology Revenue Corporate Culture Securities Law Stock Market Gene Therapy Company Financials

Wealthfront Confidentially Files for US IPO as Fintech Listings Gain Momentum

The Palo Alto-based firm has kept offer terms under wraps, building on recent strong debut performances from Chime and Circle

Eli Lilly to Acquire Verve Therapeutics for $1.3 Billion

Palantir Shares Soar on Bain AI Partnership Despite Lofty Valuations

SBC Exports Approves IPO for Travel Arm Mauji Trip in FY2025-26

NTPC Green Energy Posts Record 188% Profit Surge in Q4 FY25

Delhivery Achieves Profitability and Share Surge Following Q4 FY25 Results

Chime Publicly Files for Nasdaq IPO, Signals Growth Potential

On Holding Reports Record Sales and Raises 2025 Growth Forecast

Swiggy Shares Hit Record Low as Losses Mount and Lock-In Expiry Spurs Volatility

Uber Tightens Office Mandates and Benefits, Drawing Employee Backlash

Urban Company Files Rs 1,900 Crore IPO Draft, Targets Tech and Market Expansion

Chipotle Lowers 2025 Sales Outlook After First Same-Store Sales Dip Since 2020

ITV Studios Acquires Majority Stake in Moonage Pictures

Robinhood Reports Record Revenue and SEC Investigation Closure

Block Shares Drop 12% Following Disappointing Q4 Earnings and Outlook

Carvana Reports Record Profits but Stock Drops on Unclear 2025 Guidance

Apple Considers Adding Ads to Maps App

Uber Stock Surges After Bill Ackman Reveals $2.3 Billion Stake

SoFi Reports Record Growth but Faces Market Concerns Over Profitability